Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-06 Sale | 2023-06-08 7:00 pm | Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner | 403,758 | $6.2732 | $2,532,858 | 22,546,725 (Indirect) | View |
| 2023-05-24 Sale | 2023-05-26 8:00 pm | Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner | 545,242 | $6.4692 | $3,527,275 | 22,591,782 (Indirect) | View |
| 2022-09-15 Purchase | 2022-09-16 7:30 pm | Codiak BioSciences Inc. | CDAK | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner | 933,333 | $0 | $0 | 2,608,202 (Indirect) | View |
| 2021-08-03 Purchase | 2021-08-05 5:43 pm | Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC 10% Owner | 1,176,469 | $17 | $19,999,973 | 3,814,705 (Indirect) | View |
| 2020-10-16 Purchase | 2020-10-20 8:05 pm | Codiak BioSciences Inc. | CDAK | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner | 165,000 | $15 | $2,475,000 | 1,629,126 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion